Loading...
Alectinib-induced Immune Hemolytic Anemia in a Patient with Lung Adenocarcinoma
Drug-induced immune hemolytic anemia (DIIHA) is a rare condition with an increasing incidence associated with the frequent use of certain drugs. An 85-year-old woman with lung adenocarcinoma prescribed alectinib complained of dyspnea on exertion at our hospital. Based on her laboratory tests results...
Na minha lista:
| Udgivet i: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Japanese Society of Internal Medicine
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7946499/ https://ncbi.nlm.nih.gov/pubmed/32999219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.4241-19 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|